Fabrinet (NYSE: FN) 2026 Conference Summary Company Overview - **Company**: Fabrinet - **Industry**: Contract Manufacturing in Optical Components - **Event**: Investor Q&A session at OFC 2026 - **Date**: March 17, 2026 Key Points Growth and Financial Performance - Fabrinet reported a **36% year-over-year growth rate** in the last quarter, with a **compound annual growth rate of 16%** over the past ten years [3][5] - For FY25, the company achieved a **19% growth**, and guidance for the current quarter indicates a **35% growth** at the midpoint [5] - The telecom business saw a **59% increase** year-over-year, driven by strong demand in Data Center Interconnect (DCI) and high-performance computing (HPC) [6][8] Business Segments and Drivers - **Telecom Business**: Major growth driver, particularly in DCI, which is primarily supported by 400ZR and 800ZR technologies [9][10] - **High-Performance Computing (HPC)**: New category for Fabrinet, with revenue growing from **$15 million in Q1 to $86 million in Q2** [6][10] - **Datacom Business**: Flat revenue due to supply constraints, but demand remains strong [7][8] Capacity and Expansion Plans - Current run rate is approximately **$4.6-$4.8 billion**, with a capacity of **$5.5 billion** [37] - New facility in Chonburi, Building 10, will add **$3 billion** in capacity, bringing total capacity to **$8.5 billion** [38] - Future plans include the potential for two additional factories, each with a capacity of **$1.5 billion**, leading to a total capacity of **$11.5 billion** [38] Customer Relationships and Market Position - Fabrinet operates as a **pure play contract manufacturer**, focusing on supporting leading companies without entering the product market [14][16] - The company has established strong relationships with major customers, including AWS, and is positioned to capture significant market share in emerging technologies like Co-packaged Optics (CPO) and Optical Circuit Switching (OCS) [16][49] - Customers are providing multi-year visibility into demand, allowing Fabrinet to align capacity with future needs [8][81] Supply Chain and Operational Efficiency - The company is experiencing supply chain constraints, particularly with EML components, but improvements are expected as new sources are approved [74] - Fabrinet maintains a low operational expenditure (OpEx) of **1.5% of revenue**, which is significantly lower than industry standards [84] - The company emphasizes flexibility in operations, allowing customers to adjust their needs without financial penalties [97] Competitive Landscape - Fabrinet's unique capabilities in packaging and manufacturing processes set it apart from competitors, with **70% of manufacturing space dedicated to clean room operations** [23] - The company is well-positioned to capitalize on the growing demand for optical components driven by hyperscalers and the overall expansion of data centers [105] Future Outlook - The demand for optical components is expected to remain robust, with significant growth opportunities in DCI, HPC, and emerging technologies [106] - Fabrinet's strategy focuses on maintaining competitive pricing while ensuring high-quality service and execution for customers [32][86] Additional Insights - The company is cautious about potential risks and emphasizes the importance of execution in maintaining customer satisfaction and business growth [85] - Fabrinet's relationship with Lumentum is strong, with potential for further collaboration in the OCS market [69] This summary encapsulates the key insights and strategic directions discussed during the Fabrinet conference, highlighting the company's growth trajectory, market positioning, and operational strategies.

Core Viewpoint - Micron Technology is experiencing significant growth, with a 177% annualized earnings growth rate, driven by strong demand in data centers and artificial intelligence sectors, as it prepares to report quarterly earnings [1] Company Performance - Micron's adjusted profit for the November-ended quarter surged 167% year-over-year to $4.78 per share, while revenue increased by 57% to $13.6 billion [1] - For the upcoming February-ended quarter, Micron anticipates revenue of $18.7 billion, significantly exceeding analyst estimates of $14.3 billion [1] - The company expects a 20% increase in DRAM and NAND bit shipments for the remainder of the 2026 fiscal year [1] Market Context - The stock market is currently influenced by strong earnings reports from companies like Oracle, which has positively impacted AI-related stocks [1] - Micron's stock has shown resilience, holding near highs despite market volatility, and is undergoing a bullish test of its 10-week moving average [1] Options Trading Insights - A call option for Micron with a strike price of $407.50 had a premium of approximately $23.50 per share, representing 5.8% of the underlying stock price at the time [2] - The expected earnings-related move for Micron stock is projected to be around 46 points up or down, based on the options market [2]

Core Viewpoint - Natural Alternatives International, Inc. (NAII) has experienced significant stock declines following its second-quarter fiscal 2026 results, with a 25.3% drop compared to a 0.3% return for the S&P 500 index during the same period [1] Financial Performance - For the second quarter ended December 31, 2025, the company reported a net loss of $2.6 million, or 42 cents per diluted share, compared to a net loss of $2.2 million, or 37 cents per diluted share, in the prior-year period [2] - Net sales increased by 2% year over year to $34.8 million from $34.1 million, while gross profit improved to $2.5 million, or 7.2% of net sales, from $1.7 million, or 4.9% [2] - For the first six months of fiscal 2026, net sales rose 8% to $72.5 million from $67.2 million, and the net loss narrowed to $2.8 million, or 47 cents per share, from a $4.2 million loss, or 70 cents per share, a year earlier [3] Segment & Channel Performance - Private-label contract manufacturing, the company's core business, increased by 2% in the quarter to $32.8 million, with private-label sales climbing 9% to $68.9 million for the first six months of fiscal 2026 [4] - On a trailing 12-month basis, private-label manufacturing accounted for approximately 94.5% of total revenues, highlighting its importance in the revenue mix [4] - CarnoSyn beta-alanine royalty, licensing, and raw material sales rose 13% year over year in the second quarter to $2 million from $1.8 million, but for the first six months, CarnoSyn revenues declined 15% to $3.7 million from $4.3 million [5] Management Commentary & Operating Environment - The company faces challenges in forecasting demand from clients in multi-level marketing and direct selling channels across various regions, leading to underutilization of manufacturing capacity [7] - Despite improved gross margins and a slight decline in selling, general, and administrative expenses, the company continues to incur operating losses due to fixed manufacturing costs being spread over lower-than-expected volumes [8] - Management noted growth in other sales channels, including large retailers and internet-based direct-to-consumer sales [8] Strategic Initiatives - The company emphasizes the strategic importance of expanding the CarnoSyn patent estate, particularly through TriBsyn, a new formulation aimed at improving bioavailability [9] - There are opportunities for TriBsyn and sustained-release CarnoSyn in wellness and healthy aging markets, especially related to the use of GLP-1 medications [9] Liquidity & Financial Position - As of December 31, 2025, cash and cash equivalents totaled $3.8 million, down from $12.3 million at June 30, 2025, with working capital at $28.7 million [10] - The company had $5.8 million outstanding under its line of credit, with $10 million in available borrowing capacity, and total assets were $153.3 million with stockholders' equity at $67 million [10] Outlook - Management expects sales revenues to increase in the remaining two quarters of fiscal 2026 compared to both prior-year periods and the first half of the current fiscal year, but anticipates a net loss in the second half of fiscal 2026 [11]

Core Insights - Wasatch Global Investors reported a challenging Q4 2025 for its Small Cap Growth Strategy, with small-cap equities underperforming broader market indices due to investor caution and preference for larger stocks [1] - The Russell 2000® Growth Index gained 1.22% in Q4 2025, while the Wasatch strategy finished in negative territory, highlighting stock-specific factors rather than macroeconomic stress [1] - Biotechnology was a strong segment within small-cap stocks, with its component in the Russell 2000® Growth Index rising nearly 27% [1] - For the full year 2025, the Russell 2000 Growth Index advanced 13.01%, contrasting with the Wasatch strategy's loss, attributed to earnings volatility and valuation compression [1] Company Insights - Fabrinet (NYSE:FN) is highlighted as a significant contributor in the Q4 2025 investor letter, providing advanced optical and electronic manufacturing services [2][3] - The stock of Fabrinet had a one-month return of -0.90%, with shares trading between $464.00 and $504.03 over the last 52 weeks, and a market capitalization of approximately $17.555 billion [2] - Fabrinet's optical transceivers are noted for maintaining precise thermal control during high-speed data transmission, with increased demand driven by data center upgrades for AI workloads [3] - Despite being held by 44 hedge fund portfolios at the end of Q3 2025, Fabrinet is not among the 30 most popular stocks among hedge funds, with a belief that other AI stocks may offer higher returns in a shorter timeframe [4]

Core Insights - The FPA Queens Road Small Cap Value Fund returned -0.36% in Q4 2025, underperforming the Russell 2000 Value Index which gained 3.26% during the same period [1] - For the full year 2025, the Fund achieved a return of 13.36%, slightly outperforming the Index's 12.59% gain [1] - The Fund's strategy focuses on quality and value to protect clients from market drawdowns, but it underperformed in the second half of 2025 due to a market preference for speculative and low-quality stocks [1] Company Analysis: Fabrinet (NYSE:FN) - Fabrinet is a contract manufacturer specializing in optical networking equipment and modules, dominating its niche with impressive historical revenue growth and increasing operating margins [3] - As of February 12, 2026, Fabrinet's stock closed at $462.05 per share, with a one-month return of -6.55% and a 12-month increase of 107.16% [2] - The company reported record revenue of $1.13 billion in Q2 fiscal 2026, reflecting a 36% year-over-year growth [5] - Fabrinet's products are in high demand in data centers, particularly for training artificial intelligence models, with Nvidia being a significant customer [3] - Despite its strong position, the Fund has been trimming its holdings in Fabrinet due to concerns that stock price expectations may have outpaced actual spending in data centers [3] Hedge Fund Interest - Fabrinet was held by 44 hedge fund portfolios at the end of Q3 2025, an increase from 32 in the previous quarter [5] - The company is not listed among the 30 most popular stocks among hedge funds, indicating a mixed sentiment in the investment community [5]

Financial Data and Key Metrics Changes - For Q2 FY 2026, total revenue was $96.3 million, down from $113.9 million in the same period of FY 2025, primarily due to reduced demand from a longstanding customer and the transition of an End-of-Life program [3][4] - The net loss for Q2 FY 2026 was $8.6 million or $0.79 per share, compared to a net loss of $4.9 million or $0.46 per share in Q2 FY 2025 [7] - Adjusted gross margin for Q2 FY 2026 was 7.9%, down from 6.8% in the same period of FY 2025, while operating margin was -10.7% compared to -1.0% [5][6] Business Line Data and Key Metrics Changes - The company initiated a wind down of manufacturing operations in China, which is expected to save approximately $1.2 million per quarter once completed [5] - The company is also reducing its workforce in Mexico, aiming for savings of approximately $1.5 million per quarter [5] - The consigned materials program is ramping up, with potential revenue growth of over $25 million annually, equivalent to a $100 million turnkey program [16] Market Data and Key Metrics Changes - Inventory decreased by $12.3 million or 12% year-over-year, while accounts receivable days sales outstanding (DSOs) improved to 77 days from 99 days a year ago [8] - The company continues to face uncertainties in the global economy and volatile trade policies, impacting customer demand [4][9] Company Strategy and Development Direction - The company is focusing on nearshoring and tariff mitigation strategies to reduce costs while maintaining operational flexibility [4] - Manufacturing operations are being shifted from China to Vietnam and the U.S. to better align with strategic initiatives and customer demand [12][15] - The company anticipates that by the end of FY 2026, approximately half of its manufacturing will occur in the U.S. and Vietnam [15] Management's Comments on Operating Environment and Future Outlook - Management noted that while there are uncertainties in the global economy, new programs are gradually ramping up, and cost efficiencies from recent overhead reductions are taking hold [9][10] - The company is not providing forward-looking guidance for Q3 FY 2026 due to the uncertainty of new product ramps [10] - Management expressed confidence in the potential for profitable long-term growth despite current challenges [19] Other Important Information - The company has reduced its total debt year-over-year by approximately $13.4 million, reflecting its ability to generate cash from operations [8] - Capital expenditures for FY 2026 are expected to be around $8-$10 million, focusing on new production equipment and automation [9] Q&A Session Summary Question: Can you provide more details on the increased demand from existing customers? - Management indicated that the increased demand is primarily from two longstanding customers, with a significant revenue impact from product maturation and an End-of-Life program [23][24] Question: What is the size and timing of the new programs won? - The automotive program is expected to generate up to $5 million and will be manufactured in Mexico, while pest control and industrial equipment programs are expected to generate $2-$5 million and will be produced in the U.S. [25] Question: What are the tariff mitigation strategies being implemented? - The company is focusing on lower-cost production facilities in Vietnam and Mexico, leveraging the USMCA agreement to mitigate tariffs [26][28] Question: What is the outlook for gross margin and revenue growth? - Management expects to achieve breakeven by the end of the fiscal year, with anticipated revenue growth and margin expansion from the consigned program [40][41] Question: How is the restructuring in Mexico expected to impact future growth? - Management believes that recent efficiency improvements and automation investments will make the Mexico facility more competitive, with expectations for growth moving forward [44][45]

Core Viewpoint - Flex is set to announce its third quarter fiscal year 2026 financial results on February 4, 2026, before market opening, followed by a conference call to discuss the results [1]. Group 1: Financial Results Announcement - The financial results will be announced before the market opens on February 4, 2026 [1]. - A conference call to discuss the results will take place at 7:30 AM CT / 8:30 AM ET on the same day [1]. Group 2: Webcast Information - A live webcast of the presentation will be available on the Flex investor relations website [2]. - A replay of the webcast and supporting materials will be accessible on the investor relations website after the event [2]. Group 3: Company Overview - Flex is a manufacturing partner that assists leading brands in designing, building, and managing products aimed at improving the world [3]. - The company operates in 30 countries, providing advanced manufacturing and supply chain solutions, innovative products, and lifecycle services [3]. - In the AI era, Flex is focused on accelerating data center deployment by addressing power, heat, and scale challenges with advanced technology [3].

Core Insights - Celestica (CLS) has evolved from a lesser-known contract manufacturer to a significant player in the AI infrastructure sector, indicating a substantial transformation that the market may still be undervaluing [1] Company Overview - The company is positioned as a critical enabler of the AI infrastructure boom, suggesting strong growth potential in this emerging market [1] Investment Philosophy - The investment approach highlighted emphasizes growth prospects and the potential for high profitability within 1-2 years, aligning with the company's current trajectory [1]

Core Insights - Celestica (CLS) has evolved from a lesser-known contract manufacturer to a significant player in the AI infrastructure sector, indicating a substantial transformation that the market may still be undervaluing [1] Company Overview - The company is positioned as a critical enabler of the AI infrastructure boom, suggesting strong growth potential in this emerging market [1] Investment Perspective - The investment philosophy associated with Celestica emphasizes long-term discipline and consistent alpha generation, with a focus on companies that exhibit aggressive growth prospects [1]

Company Overview - Jabil Inc. (NYSE:JBL) is a contract manufacturer that has transformed from a low-multiple manufacturer to a company that assists clients in product design and manufacturing location decisions, which is increasingly important due to tariffs [1][2] - The company provides a range of services including manufacturing, design, and product management, serving various industries such as healthcare, automotive, and electronics [2] Financial Performance - Jabil reported a strong quarterly performance with better-than-expected guidance for the current quarter, indicating robust operational capabilities [2] - The company's share count has decreased by 43.6% since the end of 2015, reflecting a significant share buyback activity [1] Market Sentiment - Jim Cramer expressed bullish sentiment on Jabil, highlighting it as one of his favorite stocks within the contract manufacturing sector, which is currently experiencing a quiet bull market [2] - Despite an initial stock price increase of nearly 10% following the earnings report, Jabil's stock eventually retraced most of those gains due to a broader sector sell-off, although the stock has appreciated by 50% overall [1]